Family · Pharmaceutical analytical standards
Acebutolol
A cardioselective beta-blocker with intrinsic sympathomimetic activity, patented in 1967 and in use since 1973 for high blood pressure, angina and arrhythmias. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?The '-olol' suffix marks beta-blockers; in the liver acebutolol becomes diacetolol, a metabolite that is just as active and lasts longer than the parent drug.
No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
